Renowned practitioners, uniquely resourced
As one of the nation’s largest hemophilia treatment centers, the Indiana Hemophilia & Thrombosis Center (IHTC) is uniquely resourced. We conduct advanced research and training to improve blood disorder treatment nationwide. Our lifespan, multi-disciplinary approach allows us to deliver continuity of care from birth through adulthood, and to help patients improve every aspect of their lives.
Our team members function at the highest levels and enjoy a collegial atmosphere with other renowned practitioners nationally and internationally. We’re deeply committed and passionate about what we do. To join us, consider our job openings below.
IHTC hematologists are known for advanced research and innovative treatment protocols. Our unique multi-disciplinary team combines specially trained hematologists, nurses, nurse practitioners, physician assistants, mental health providers, physical therapists, dental hygienists, counselors, and pharmacists dedicated to providing exceptional care to our blood disorder patients.
We’re committed to delivering top-tier training to our own staff as well as to other medical professionals from across the nation who learn from our success. Continual learning and development characterize IHTC staff members of all types and at all levels. We seek to achieve ever-increasing levels of excellence and effectiveness in blood disorder treatment.
As the only federally recognized hemophilia treatment center in Indiana, IHTC is the recipient of multiple awards, grants, and national recognition. IHTC holds extremely high standards for performance and patient care. Above all, we’re driven by our commitment to improving the lives of our blood disorder patients, and we’re always working to push the boundaries of possibility.
Learn more about our Center of Excellence
The Indiana Hemophilia & Thrombosis Center (IHTC) is committed to providing the highest quality comprehensive services and holistic care to patients with bleeding, clotting, and other hematologic disorders, and to their families.
A future where people with rare blood disorders flourish